Suchergebnisse
Vor einem Tag · As XRP heads into the final quarter of 2024, the convergence of technical analysis, whale behavior, and the Ripple vs SEC case presents a potentially transformative period for the cryptocurrency. If the legal uncertainties are resolved favorably and technical patterns hold, XRP could be poised for a significant price increase, potentially reaching or surpassing the $1 mark.
Vor 5 Tagen · About XRP. Launched in 2021, the XRP Ledger (XRPL) is an open-source, permissionless, and decentralized technology. Benefits of the XRP Ledger include its low cost ($0.0002 to transact), speed (settling transactions in 3-5 seconds), scalability (1,500 transactions per second), and inherently green attributes (carbon-neutral and energy-efficient).
Vor 2 Tagen · XRP price has managed to hold strong around the $0.6 level as the crypto market crashed. Expect more volatility following Ripple's case outcome later today. XRP price eyes $0.76 ahead of the SEC's closed meeting. Hashdex Nasdaq Crypto Index ETF just added XRP to its portfolio. XRP Open Interest and ...
28. Juni 2024 · Ripple’s CEO Brad Garlinghouse is hopeful for a spot XRP ETF. The Ripple vs SEC lawsuit enters the crucial trial stage. Traders scan the market for buy the dip opportunities as XRP bounces back. XRP price struggles to find direction as the tide turns for the eighth-largest crypto, boasting $26.5 ...
12. Juli 2024 · Ripple (XRP) traders’ sentiment turned positive on Friday, as CEO Brad Garlinghouse highlighted the addition of XRP-Dollar reference rate and indices to the CME Group and CF Benchmarks.
Vor 4 Tagen · Find XRP news now at The Crypto Basic Stay informed with the latest Ripple crypto updates, including price news, market analysis, and expert insights
14. Juli 2024 · However, if the bullish momentum persists, XRP could continue its upward trajectory. Huge Surge in XRP. Ripple’s XRP has recently extended its seven-day gains, rising by 19%, according to CoinGecko data. The US SEC filed a response to Ripple's motion, which opposes the company's plans to seal and redact evidence related to remedy briefings.
